Sivelestat (EI546) sodium is a competitive inhibitor of human neutrophil elastase , with an IC 50 of 44 nM and a K i of 200 nM. Sivelestat (EI546) sodium has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19 .